PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE

PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE

2019 Value in Health

Kalogeropoulou, M. | Gkouvitsos, I. | Barlogiannis, T. | Bowrin, K. | Briere, J.B. | Millier, A. | Karabis, A. | Volume: 22, Issue: , Pages: S555,